계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Nectero Medical
company
About
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $19.50M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$19.50M
Nectero Medical has raised a total of
$19.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 10, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 10, 2021 | Series C | $19.50M | 1 |
Boston Scientific
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Nectero Medical is funded by 1 investors.
Boston Scientific
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Boston Scientific
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
